Melanoma Coverage from Every Angle

Alexander N. Shoushtari, MD, on Toxicities of Nivolumab

Posted: Friday, May 18, 2018

When re-starting treatment with nivolumab after a dose held for toxicity, how common is it for the same adverse effect to develop again?

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.